AMEX · Medical - Devices

Electromed, Inc. (ELMD) Stock

$27.97 +0.61% AMEX: ELMD Healthcare

Valuation

MetricValue
Price$27.97
Market Cap$231.59M
P/E Ratio20.42
P/B Ratio4.28
P/S Ratio4.74
EPS (TTM)$1.03
52-Week High$47.40
52-Week Low$23.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE23.38%
ROA17.05%
ROCE25.93%
Gross Margin78.44%
Operating Margin18.55%
Net Margin15.32%
Debt/Equity0.00
Current Ratio4.50

Annual Financials (USD)

Metric20222023202420252026
Revenue$42.0M$48.0M$55.0M$64.0M$74.0M
Operating Profit$3.0M$4.0M$7.0M$10.0M$14.0M
Net Profit$2.0M$3.0M$5.0M$8.0M$11.0M
EPS$0.26$0.36$0.58$0.86$1.30
Op Margin7.1%8.3%12.0%15.4%18.8%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$41.0M$46.0M$52.0M$54.0M$66.0M
Total Liabilities$7.0M$8.0M$8.0M$11.0M$12.0M
Cash$8.0M$7.0M$16.0M$15.0M$20.0M
Borrowings$0$0$0$0$0

Latest News

4 Low-Beta Stocks to Minimize Portfolio Risk: LQDA, FLXS, ELMD & AGX Zacks · Jul 10, 2026 Electromed (ELMD) Is a Great Choice for 'Trend' Investors, Here's Why Zacks · Jul 6, 2026 ELV Accelerates Clinical Reviews Through Health OS Platform Zacks · Jun 24, 2026 Here's Why Momentum in Electromed (ELMD) Should Keep going Zacks · Jun 19, 2026 Electromed Insider Sold Shares Worth $354,095, According to a Recent SEC Filing MT Newswires · Jun 9, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-1.0M$1.0M$9.0M$11.0M$10.0M
Investing Cash Flow$-3.0M$-3.0M$-1.0M$-1.0M$-3.0M
Financing Cash Flow$-2.0M$0$0$-12.0M$-4.0M
Net Cash Flow$-4.0M$-1.0M$9.0M$-1.0M$5.0M
Free Cash Flow$-2.0M$0$9.0M$11.0M$8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.38
EV / EBITDA22.02
FCF Yield3.40%
Quick Ratio4.39
Interest Coverage0.00
Return 1Y100.31%
Return 3Y244.27%
Return 5Y273.86%

Ownership

Insiders Held17.18%
Institutions Held58.33%
Institutions Float Held70.43%
Institutional HolderSharesReport Date
J.e. Simmons & Co., P.c.492,8222026-03-31
Blackrock Inc.458,8452026-03-31
Vanguard Capital Management LLC335,0282026-03-31
Punch & Associates Investment Management, Inc.224,5202026-03-31
Acadian Asset Management. LLC222,7552026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $334.73 -1.67% 38.93 $4.92T 0.32%
MSFTMicrosoft Corporation $535.03 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $354.31 +1.73% 16.94 $4.29T 0.26%
AMZNAmazon.com, Inc. $261.46 +2.91% 19.82 $2.81T 0.00%
METAMeta Platforms, Inc. $724.11 +0.45% 27.93 $1.84T 0.28%

About Electromed, Inc.

Electromed, Inc. is led by CEO James L. Cunniff, employs 174 people, headquartered in US, publicly traded since 2010.

Electromed, Inc. (ELMD) stock trades at $27.97 with a market capitalization of $231.59M. The stock is valued at a price-to-earnings (P/E) ratio of 20.42, price-to-book of 4.28, price-to-sales of 4.74. Over the past 52 weeks the stock has ranged between $23.01 and $47.40, and currently trades 41.0% below its 52-week high.

On profitability, Electromed, Inc. generates a return on equity (ROE) of 23.38% — well above the market average, a sign of a high-quality business, return on capital employed of 25.93%, an operating margin of 18.55%, a net profit margin of 15.32%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1178.88 +0.79% JNJ Johnson & Johnson $260.45 +1.55% ABBV AbbVie Inc. $276.98 +1.67% MRK Merck & Company, Inc. Common Stock (new) $145.34 +2.08% UNH UnitedHealth Group Incorporated Common Stock (DE) $376.24 +1.43% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $658.31 +0.97% AMGN Amgen Inc. $413.31 +1.44% GILD Gilead Sciences, Inc. $150.80 +2.52% ABT Abbott Laboratories $99.69 +1.21% NVO Novo Nordisk A/S $38.39 +0.54%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides